What did Ã–ssur pay for Fior & Gentz?

$120.0M, equivalent to 17.4× EBITDA / 5.20× revenue. Target revenue was approximately $23.0M. Target EBITDA was approximately $6.9M.

ACQUIRED · 2024

Who Acquired Fior & Gentz?

Ã–ssur · $120.0M· 17.4× EBITDA

Fior & Gentz was acquired by Ã–ssur in 2024 for $120.0M. The deal was priced at 17.4× EBITDA / 5.20× revenue.

Revenue

$23.0M

EBITDA

$6.9M

Deal value

$120.0M

EV / EBITDA

17.4×

Owen Mumford Holdings · acquired by Embecta in 2026 · $201.0M
Acera Surgical · acquired by Solventum in 2025 · $725.0M
Alydia Health (Organon JADA System) · acquired by Laborie Medical Technologies in 2025 · $440.0M
B Medical Systems (Azenta) · acquired by THELEMA S.A. R.L. in 2025 · $63.0M
BIOTRONIK Vascular Intervention Business · acquired by Teleflex, Inc. in 2025 · $875.9M

Three fields, instant range, backed by 25,592 real M&A transactions including this one.